Codice QR

Assessment of Exenatide Extended‐Release for Maintenance of Diabetic Remission in Cats

ABSTRACT Background Insulin‐treated diabetic cats frequently achieve transient remission. The glucagon‐like peptide‐1 receptor agonist, exenatide extended‐release (exenatide‐ER), preserves β cell function in people with type 2 diabetes mellitus (DM). Objectives Investigate the effect of exenatide‐ER...

Descrizione completa

Salvato in:
Autori principali: Chen Gilor, Linda M. Fleeman, Sean E. Hulsebosch, Stijn J. M. Niessen, Charlotte R. Bjørnvad, Jully Pires, Katarina Hazuchova, Jocelyn Mott, Allison L. O'Kell, Ruth Gostelow, Adam J. Rudinsky, Audrey K. Cook
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2025-03-01
Serie:Journal of Veterinary Internal Medicine
Soggetti:
diabetes mellitus
feline
GLP‐1
glucagon
remission
weight loss
Accesso online:https://doi.org/10.1111/jvim.70069
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi